Literature DB >> 9210255

Gadolinium chloride toxicity in the rat.

A J Spencer1, S A Wilson, J Batchelor, A Reid, J Rees, E Harpur.   

Abstract

Groups of 10 male and 10 female Sprague-Dawley rats were given a single intravenous injection of gadolinium chloride solution at dosages of 0 (saline vehicle), 0.07, 0.14, and 0.35 mmol/kg. Apart from 1 top-dose female, which died during dosing, 5 rats/sex/ group were necropsied 48 hr postdose, and the remaining 5 rats/sex/group were necropsied 14 days postdose. Macroscopic, hematological, and clinical chemistry analyses were undertaken on all animals that were necropsied. Histopathological examination was undertaken on all organs from high-dose and control animals necropsied 48 hr postdose and on tissues that showed treatment-related changes from all other rats necropsied either 48 hr or 14 days postdose. Major lesions related to gadolinium chloride administration consisted of mineral deposition in capillary beds (particularly lung and kidney), phagocytosis of mineral by the mononuclear phagocytic system, hepatocellular and splenic necrosis followed by dystrophic mineralization, mineralization of the fundic glandular mucosa in the absence of necrosis followed by mucous cell hyperplasia, decreased platelet numbers and increased prothrombin time, and activated partial thromboplastin time. Electron microscopy and x-ray microanalysis of the spleen and liver revealed electron-dense deposits in splenic macrophages, Kupffer cells, and hepatocytes composed of gadolinium, calcium, and phosphate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210255     DOI: 10.1177/019262339702500301

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  29 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 2.  The Impact of Excess Ligand on the Retention of Nonionic, Linear Gadolinium-Based Contrast Agents in Patients With Various Levels of Renal Dysfunction: A Review and Simulation Analysis.

Authors:  John P Prybylski; Michael Jay
Journal:  Adv Chronic Kidney Dis       Date:  2017-05       Impact factor: 3.620

3.  Magnetic Resonance Imaging of Reptiles, Rodents, and Lagomorphs for Clinical Diagnosis and Animal Research.

Authors:  Joanna Głodek; Zbigniew Adamiak; Adam Przeworski
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

4.  Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats.

Authors:  Yì-Xiáng J Wáng; Joseph Schroeder; Heiko Siegmund; Jean-Marc Idée; Nathalie Fretellier; Gaëlle Jestin-Mayer; Cecile Factor; Min Deng; Wei Kang; Sameh K Morcos
Journal:  Quant Imaging Med Surg       Date:  2015-08

5.  Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats.

Authors:  Xueming Wu; Yuda Zong; Zhen Ye; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2010-07       Impact factor: 4.200

Review 6.  Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.

Authors:  Joel Garcia; Stephen Z Liu; Angelique Y Louie
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2017-11-28       Impact factor: 4.226

7.  Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Authors:  Li-Juan Fu; Jin-Xia Li; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2008-10-25       Impact factor: 3.358

8.  The fate of Gd and chelate following intravenous injection of gadodiamide in rats.

Authors:  Grete Mørk Kindberg; Steinar Uran; Grete Friisk; Ivar Martinsen; Tore Skotland
Journal:  Eur Radiol       Date:  2010-02-16       Impact factor: 5.315

9.  Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Authors:  Alicia H Clementi; Allison M Gaudy; Nico van Rooijen; Robert H Pierce; Robert A Mooney
Journal:  Biochim Biophys Acta       Date:  2009-08-20

Review 10.  Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.

Authors:  Hale Ersoy; Frank J Rybicki
Journal:  J Magn Reson Imaging       Date:  2007-11       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.